Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis

NCT02945280 is registered in ClinicalTrials.gov with Intermountain Health Care, Inc. as lead sponsor.

NCT NCT02945280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02945280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis
Lead sponsor
Intermountain Health Care, Inc.
Phase
Phase 4
Overall status
Terminated
Start date
February 22, 2017
Completion date
November 11, 2021
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis, deep venous thrombosis, thrombus, upper extremity deep venous thrombosis, venous thromboembolism